Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2001-02, Vol.33 (1-2), p.1044-1045
Main Authors: Zaltzman, J, McAlister, V, Russell, D, Halloran, P, Landsberg, D, Busque, S, Shoker, A, Boucher, A, Shapiro, J, Tchervenkov, J, Peets, J
Format: Article
Language:English
Subjects:
Acute Disease
Adult
Aged
Biological and medical sciences
Combined Modality Therapy
Female
Graft Rejection - prevention & control
Humans
Immunomodulators
Immunosuppressive Agents - therapeutic use
Kidney Transplantation - immunology
Male
Medical sciences
Middle Aged
Mycophenolic Acid - analogs & derivatives
Mycophenolic Acid - therapeutic use
Pharmacology. Drug treatments
Tacrolimus - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c390t-9fb6533e08aac98d3f8d2e6afa3e31c474189deae34d51e1f75f121ba4a6ba83
cites cdi_FETCH-LOGICAL-c390t-9fb6533e08aac98d3f8d2e6afa3e31c474189deae34d51e1f75f121ba4a6ba83
container_end_page 1045
container_issue 1-2
container_start_page 1044
container_title Transplantation proceedings
container_volume 33
creator Zaltzman, J
McAlister, V
Russell, D
Halloran, P
Landsberg, D
Busque, S
Shoker, A
Boucher, A
Shapiro, J
Tchervenkov, J
Peets, J
description
doi_str_mv 10.1016/S0041-1345(00)02323-X
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77002186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S004113450002323X</els_id><sourcerecordid>77002186</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-9fb6533e08aac98d3f8d2e6afa3e31c474189deae34d51e1f75f121ba4a6ba83</originalsourceid><addsrcrecordid>eNqFkEtvEzEQgC0EoqHwE0A-oAqkLHjsfZ5QVdFSKRUHcujNmtjjxLAv7N1K_fe4zQq49eTx6JvXx9hbEJ9AQPn5hxA5ZKDy4oMQH4VUUmW3z9gK6kplspTqOVv9RU7Yqxh_ivSXuXrJTgBkWUGtVmy_RROG1ndzXPObm8s1jxOFwds1x97y880V910398N0oIDjPXdD4Ae_Pyzpdth7gy0PPv7igfoUTgH7OLbYTylh_Oipn-Jr9sJhG-nN8p6y7eXX7cW3bPP96vrifJMZ1Ygpa9yuLJQiUSOaprbK1VZSiQ4VKTB5lUPdWEJSuS2AwFWFAwk7zLHcYa1O2dmx7RiG3zPFSXc-GmrTNjTMUVeVEBLqMoHFEUzXxxjI6TH4DsO9BqEfBOtHwfrBnhZCPwrWt6nu3TJg3nVk_1UtRhPwfgEwJjEuyTA-_te9zBuQCftyxCjJuPMUdDRJlCHrk7RJ28E_sckfCJiYuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77002186</pqid></control><display><type>article</type><title>Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Zaltzman, J ; McAlister, V ; Russell, D ; Halloran, P ; Landsberg, D ; Busque, S ; Shoker, A ; Boucher, A ; Shapiro, J ; Tchervenkov, J ; Peets, J</creator><creatorcontrib>Zaltzman, J ; McAlister, V ; Russell, D ; Halloran, P ; Landsberg, D ; Busque, S ; Shoker, A ; Boucher, A ; Shapiro, J ; Tchervenkov, J ; Peets, J</creatorcontrib><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/S0041-1345(00)02323-X</identifier><identifier>PMID: 11267183</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acute Disease ; Adult ; Aged ; Biological and medical sciences ; Combined Modality Therapy ; Female ; Graft Rejection - prevention &amp; control ; Humans ; Immunomodulators ; Immunosuppressive Agents - therapeutic use ; Kidney Transplantation - immunology ; Male ; Medical sciences ; Middle Aged ; Mycophenolic Acid - analogs &amp; derivatives ; Mycophenolic Acid - therapeutic use ; Pharmacology. Drug treatments ; Tacrolimus - therapeutic use</subject><ispartof>Transplantation proceedings, 2001-02, Vol.33 (1-2), p.1044-1045</ispartof><rights>2001 Elsevier Science Inc.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-9fb6533e08aac98d3f8d2e6afa3e31c474189deae34d51e1f75f121ba4a6ba83</citedby><cites>FETCH-LOGICAL-c390t-9fb6533e08aac98d3f8d2e6afa3e31c474189deae34d51e1f75f121ba4a6ba83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1064912$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11267183$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zaltzman, J</creatorcontrib><creatorcontrib>McAlister, V</creatorcontrib><creatorcontrib>Russell, D</creatorcontrib><creatorcontrib>Halloran, P</creatorcontrib><creatorcontrib>Landsberg, D</creatorcontrib><creatorcontrib>Busque, S</creatorcontrib><creatorcontrib>Shoker, A</creatorcontrib><creatorcontrib>Boucher, A</creatorcontrib><creatorcontrib>Shapiro, J</creatorcontrib><creatorcontrib>Tchervenkov, J</creatorcontrib><creatorcontrib>Peets, J</creatorcontrib><title>Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><subject>Acute Disease</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Graft Rejection - prevention &amp; control</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney Transplantation - immunology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mycophenolic Acid - analogs &amp; derivatives</subject><subject>Mycophenolic Acid - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Tacrolimus - therapeutic use</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkEtvEzEQgC0EoqHwE0A-oAqkLHjsfZ5QVdFSKRUHcujNmtjjxLAv7N1K_fe4zQq49eTx6JvXx9hbEJ9AQPn5hxA5ZKDy4oMQH4VUUmW3z9gK6kplspTqOVv9RU7Yqxh_ivSXuXrJTgBkWUGtVmy_RROG1ndzXPObm8s1jxOFwds1x97y880V910398N0oIDjPXdD4Ae_Pyzpdth7gy0PPv7igfoUTgH7OLbYTylh_Oipn-Jr9sJhG-nN8p6y7eXX7cW3bPP96vrifJMZ1Ygpa9yuLJQiUSOaprbK1VZSiQ4VKTB5lUPdWEJSuS2AwFWFAwk7zLHcYa1O2dmx7RiG3zPFSXc-GmrTNjTMUVeVEBLqMoHFEUzXxxjI6TH4DsO9BqEfBOtHwfrBnhZCPwrWt6nu3TJg3nVk_1UtRhPwfgEwJjEuyTA-_te9zBuQCftyxCjJuPMUdDRJlCHrk7RJ28E_sckfCJiYuA</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>Zaltzman, J</creator><creator>McAlister, V</creator><creator>Russell, D</creator><creator>Halloran, P</creator><creator>Landsberg, D</creator><creator>Busque, S</creator><creator>Shoker, A</creator><creator>Boucher, A</creator><creator>Shapiro, J</creator><creator>Tchervenkov, J</creator><creator>Peets, J</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010201</creationdate><title>Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients</title><author>Zaltzman, J ; McAlister, V ; Russell, D ; Halloran, P ; Landsberg, D ; Busque, S ; Shoker, A ; Boucher, A ; Shapiro, J ; Tchervenkov, J ; Peets, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-9fb6533e08aac98d3f8d2e6afa3e31c474189deae34d51e1f75f121ba4a6ba83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acute Disease</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Graft Rejection - prevention &amp; control</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney Transplantation - immunology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mycophenolic Acid - analogs &amp; derivatives</topic><topic>Mycophenolic Acid - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Tacrolimus - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zaltzman, J</creatorcontrib><creatorcontrib>McAlister, V</creatorcontrib><creatorcontrib>Russell, D</creatorcontrib><creatorcontrib>Halloran, P</creatorcontrib><creatorcontrib>Landsberg, D</creatorcontrib><creatorcontrib>Busque, S</creatorcontrib><creatorcontrib>Shoker, A</creatorcontrib><creatorcontrib>Boucher, A</creatorcontrib><creatorcontrib>Shapiro, J</creatorcontrib><creatorcontrib>Tchervenkov, J</creatorcontrib><creatorcontrib>Peets, J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zaltzman, J</au><au>McAlister, V</au><au>Russell, D</au><au>Halloran, P</au><au>Landsberg, D</au><au>Busque, S</au><au>Shoker, A</au><au>Boucher, A</au><au>Shapiro, J</au><au>Tchervenkov, J</au><au>Peets, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>33</volume><issue>1-2</issue><spage>1044</spage><epage>1045</epage><pages>1044-1045</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>11267183</pmid><doi>10.1016/S0041-1345(00)02323-X</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2001-02, Vol.33 (1-2), p.1044-1045
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_77002186
source ScienceDirect Freedom Collection 2022-2024
subjects Acute Disease
Adult
Aged
Biological and medical sciences
Combined Modality Therapy
Female
Graft Rejection - prevention & control
Humans
Immunomodulators
Immunosuppressive Agents - therapeutic use
Kidney Transplantation - immunology
Male
Medical sciences
Middle Aged
Mycophenolic Acid - analogs & derivatives
Mycophenolic Acid - therapeutic use
Pharmacology. Drug treatments
Tacrolimus - therapeutic use
title Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A39%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tacrolimus,%20MMF,%20steroid,%20and%20ALG%20immunotherapy%20for%20high%20immunological%20risk%20renal%20transplant%20recipients&rft.jtitle=Transplantation%20proceedings&rft.au=Zaltzman,%20J&rft.date=2001-02-01&rft.volume=33&rft.issue=1-2&rft.spage=1044&rft.epage=1045&rft.pages=1044-1045&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/S0041-1345(00)02323-X&rft_dat=%3Cproquest_cross%3E77002186%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-9fb6533e08aac98d3f8d2e6afa3e31c474189deae34d51e1f75f121ba4a6ba83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77002186&rft_id=info:pmid/11267183&rfr_iscdi=true